AUCTORES
Globalize your Research
Review Article | DOI: https://doi.org/10.31579/2578-8949/155
1 Riggs Pharmaceuticals, Karachi, Department of Pharmacy, University of Karachi-Pakistan.
2 Department of Pharmacology Fazaia Ruth Pfau Medical College Air University Karachi, Pakistan.
3 Pharmaceutical Inc OPJS University Rajasthan India.
*Corresponding Author: Rehan Haider, Riggs Pharmaceuticals, Karachi, Department of Pharmacy, University of Karachi-Pakistan.
Citation: Rehan Haider, Asghar Mehdi Head, Geetha Kumari, (2024), The Role and Impact of Generics in Pharmaceutical Markets, Dermatology and Dermatitis, 9(3); DOI:10.31579/2578-8949/155
Copyright: © 2024, Rehan Haider. This is an open-access article distributed under the terms of The Creative Commons. Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
Received: 15 April 2024 | Accepted: 25 April 2024 | Published: 03 May 2024
Keywords: generics; pharmaceutical manufacturing; advertising dynamics; supervisory foundations; healthcare commerce; affordability; competition; bioequivalence; retail seepage; novelty
Generics, an essential component of drug manufacturing, represent copies of brand-name drugs whose patents have passed away. This abstract investigates the significance of generics in healthcare, their effect on display movement, regulatory foundations, and healthcare commerce.
Generics play an important role in extending the patient approach to affordable cures while supporting contests in pharmaceutical advertising. They offer economical alternatives to brand-name drugs, forceful unhappy healthcare payments, and improving drug devotion. However, concerns concerning quality, security, and productiveness persist, making necessary tight supervisory oversight and bioequivalence experiments to guarantee therapeutic similarity accompanying their brand-name matches.
Key stakeholders, including healthcare providers, subjects, insurers, and policymakers, are progressively embracing generics by way of lightening rising healthcare costs and improving healthcare sustainability. Market currents display a growing inclination for generics on account of their lower prices, driving advertise seepage and growing market share.
Regulatory instrumentalities general have achieved policies to advance the use of generics, containing expedited authorization pathways, patent expirations, and inducements for general manufacturers. These initiatives aim to promote contests, incentivizes change, and provoke retail entry, eventually enhancing customers and healthcare systems alike.
Challenges front the generics manufacturing include protected property created by original thought rights, supply chain disruptions, and supervisory obstacles to market entrance. Additionally, the rise of complex generics, biosimilars, and specialty generics poses singular challenges in conditions of happening, manufacturing, and advertising agreements.
In conclusion, generics show a cornerstone of healthcare, contribute inexpensive alternatives to brand-name drugs, and forceful contest and novelty in pharmaceutical advertising. Through cooperation between managers, manufacturers, and healthcare partners, generics manufacturing can continue to develop and bloom, guaranteeing an equitable approach to essential cures and advancing worldwide fitness effects.
Generic drugs, famous by their auction under generic names alternatively distinguishing brand names, play a lively role in drug markets. Approved through a shortened process utilizing a tainted drug as a reference, generics offer a sleek road to advertising entry. Instead of far-reaching security and efficiency trials, common guests need to explain either identical arrangements or bioequivalence to the remark merchandise. This approach significantly reduces the moment of truth and cost of authorization. However, general authorization and launch are as long as patent and supervisory uniqueness periods, which motivate inventor parties to develop new drugs (1).
The record of common drugs spans decades, accompanying examples like an anesthetic, a centennial-traditional compound, immediately sold generically because allure fundamental patent expired. Despite their real ancestries, the generics manufacturing now rivals the stigmatized drug advertise in scale. In the United States, common drug sales comprise nearly 40% of the stock exchange, reflecting their meaningful demeanor. In many nations, this portion is even higher, underscoring the extensive ratification and agreement of generic cures (2).
The great compromise history of generics versus big pharma in the United States
Drug manufacturing in the United States is frequently divided into two main areas: Big Pharma and Generics, each accompanying specific trade models and objectives. Big Pharma focuses on uncovering and dominating new cures, trading bureaucracy at prices reflecting the costs of the test. These prices are frequently considerably above manufacturing costs, accompanying profits reinvested into further change. Generics, in another way, are used by change into cash-patent medicines, benefiting from lower production and announcing costs. Consequently, general drugs are usually sold at significantly lower prices distinguished from their brand-name matches, frequently at a 70-90% discount.
Historically, two together Big Pharma and Generics have faced challenges in guiding along the route, often over water supervisory processes in the United States. In the late 1970s and early 1980s, two together subdivisions petitioned Congress for a declaration removing blame seen biases. Big Pharma deplored the delay middle from two points in patent approval and supervisory go-ahead, all the while that time patent history was belittled. Regulatory authorization, managed by apiece Food and Drug Administration (FDA), could be enduring, chief to absent buying and uncertainty. While few relaxations maybe wanted through kind courts, outcomes were irregular and doubtful.
Generics confronted their own set of hurdles, especially the failure to conduct experimental help FDA authorization just before patents lapsed. This meant they frequently met delays in leading their drugs to advertise, obstructing their ability to face efficiently.
Despite differences and irregularities within the manufacturing, these fundamental actions have formed the friendship between Big Pharma and Generics in the United States. Balancing innovation inducements accompanying approachability and affordability debris a challenge at the heart of drug procedure and management.
The Drug Price Competition & Patent Term Restoration Act of 1984, usually famous as Hatch-Waxman, arose as a response to the drug manufacturing's contesting petitions for remedy concerning patent infringement and supervisory hurdles. Under this regulation, Big Pharma acquires the convenience of patent term enlargement if FDA delays occur all along the authorization process. The continuation, conceivably until five years, was accepted administratively outside the need for community legal proceedings.
Generics more benefited considerably under Hatch-Waxman. They were immediately intelligent enough to file a shortened New Drug Application (ANDA), that required no security and productiveness dossier but depended on existing FDA-held dossier. Instead, generics fixated on professed bioequivalence, considerably lowering costs and time. The definitive hurdle for generics was the Paragraph IV confirmation, place they commit insist that their proposed drug did not violate existent patents or that the patents were invalid. However, this confirmation drew patent infringement lawsuits, putting off FDA authorization as far as determination.
Despite the risks, Paragraph IV confirmation offered solid rewards for generics. If favorable in invalidating a patent, the generics guest relished an ending of exclusivity, usually six months, place they keep moving their drug outside competition from different generics. During this ending, prices waited approximately extreme, providing a significant commercial inducement for disputing patients
Seeking generic approval in the United States
In the United States, common drug authorization attends two main routes, each tailored to the distinguishing traits of the drug being inspected.
The more low route is the Abbreviated New Drug Application (ANDA). This pathway demands that the general output holds the same alive factor, portion of drug or other consumable, route of presidency, and indication as the remark drug. Bioequivalence between the common and remark products is a key necessity, explained through pharmacokinetic and pharmacodynamic studies. While ancestry-level calculations suffice for spoken formulations, alternative means are unavoidable for drugs accompanying localized action or injectable formulations.
The second route called the 'paper NDA,' is applied when the general product varies from the citation drug in arrangement or use. Unlike ANDAs, paper NDAs are inspected similarly to balanced NDAs, admitting for tests further simple bioequivalence in active enlists. These troubles concede the possibility of referencing earlier certified drug produce or written data, in a kindly manner driven on a case-by-case action. Both creator and general companies can use this route, accompanying happening commodity conceivably not being bioequivalent to the reference drug.
Generic drugs must obey tight control of product quality and production standards analogous to stigmatized drugs. Approval makes necessary intersection batch necessities for similarity, substance, innocence, and quality, by FDA's good production practice organizing.
Regardless of the authorization route, generic aspirants must specify patent certifications and guide along the route, often over water enrollment data uniqueness periods. No general translations of a new synthetic entity may be certified just before five age after allure primary authorization, accompanying a three-year uniqueness ending for new clues or formulations. Extensions are likely for pediatric trials. Data uniqueness periods are filed in the 'Orange Book,' written for one FDA and available electronically, leading general drug planners in their supervisory journey.
Generic approval process outside the United States
Outside the United States, common drug authorization processes change but often feature the Abbreviated New Drug Application (ANDA) process promoted in the US. Applicants usually demonstrate similarity in a portion of drug or other consumable, alive element, and drug form compared to the remark fruit. Bioequivalence accompanying the citation commodity is also a low necessity.
Under the General Agreement on Tariffs and Trade (GATT) accords, all World Trade Organization (WTO) nations must offer a few forms of registration dossier uniqueness periods. In Europe, dossier and shopping uniqueness rules delay generic produce launches until 10 or 11 age afterwards the first approval of the live stuff. Japan usually imposes a six-period dossier exclusivity ending for new synthetic bodies.
Unlike in the United States, Europe and Japan lack processes complementary to the US Orange Book listing and Paragraph IV challenge. Patent keepers in these domains must generally wait as far as the launch of a violating output to sanction their patents.
The substance of the common industries in miscellaneous nations depends on management organizing, patent laws, and display action. For instance, France and many in the southern European nations have absolute price controls on branded production, developing in a tinier effect price when patents lapse. Japan's higher-valued stigmatized commodity and restricted incentives for common replacement cause comparably tinier generic drug manufacturing.
In contrast, nations like the United Kingdom and Germany have no price caps but offer management compensation levels that decrease when generics become available, supporting important retail share for common associations. The United States, with extreme prices for tainted drugs and powerful inducements for generic replacement, determines conceivably big profits for the first common on the market but knowledge of speedy price deterioration accompanying raised competition.
Additionally, nations accompanying historically feeble patent care may present an image of production bases for output destined for markets accompanying stronger patent care, despite lower household advertise value.
Biopharmaceuticals
Biopharmaceuticals, as known or named at another time or place biogenerics, present a singular challenge for the generics industry on account of their complex character and extreme manufacturing costs. Unlike established drugs, which are usually small synthetic individuals, biopharmaceuticals are abundant, complex compounds such as development birth control methods, interferon, and erythropoietin. With over 100 aforementioned products on the stock exchange, the potential common advertise for biopharmaceuticals is substantial, bulged in a lot of US currency.
However, the regulatory pathways for biopharmaceuticals are not also outlined as those for limited chemical bodies like usual drugs. Unlike the modernized approval processes supported by blueprints in the way that Hatch-Waxman, there is no generally recognized system for proving bioequivalence for biopharmaceuticals. This lack of harmonious resources that general companies grant permission should conduct complete safety and efficiency tests, a priceless and late endeavor that negates the adeptness acquired through supervisory frameworks like Hatch-Waxman.
Furthermore, the extreme production costs guide biopharmaceuticals making it troublesome for general parties to undercut brand drugs for one important border seen accompanying established limited chemical individuals. This alliance of supervisory changeableness and manufacturing expenses presents difficult hurdles for general companies pursuing to introduce biopharmaceutical advertising. As a result, progress in this area proper expected to slow in the anticipated future.
Blurring the lines
The drug countryside, often constructed as a division betwixt Generics and Big Pharma, is more nuanced than originally perceived. While Big Pharma usually blooms on premium reducing under patent protection, generics associations more energetically chase patents for various reasons.
Firstly, in the vying generics display, patents on new formulations, production processes, or various forms of existing compounds can hold important worth. While not as productive as original patents held by Big Pharma, these patents offer competing benefits in a congested forum, especially if they look after economically advantageous changes.
Secondly, some generics guests harbor goals of transitioning into Big Pharma or cultivating their stigmatized medicines. These parties purchase research conveniences to discover creative drugs, fogging foul line middle from two points generics and branded pharmaceuticals.
Furthermore, Big Pharma itself has risked the generics retail. This connection includes the direct purchase of generics something added or charming in guard and licensing agreements accompanying generics associations. These cooperations grant permission involving giving the demand of certain products or licensing valuable talent had a connection with fruit approaching patent expiration.
Such participation may be clever, especially when the fruit is nearing the patent end, and the patent keeper prefers not to sell it generically. By licensing skills to generic guests, the patent owner can gain an advantage while permissive the generic guest to record stock exchange competitively.
Overall, the distinction between Generics and Big Pharma is progressively fogged, with two together hands charming in patent blueprints and collaborations to guide along the route, often watering the complicatedness of drug manufacturing.
The future
Drug manufacturing has witnessed meaningful fortification over the decades, accompanying many prominent Big Pharma guests from the 1950s to the 1980s vanishing on account of mergers or acquisitions. This flow is copied in the generics area, where fortification has increased in recent ages.
The forceful forces behind this combination are likely similar to those in additional labors: frugality of scale and the strategic necessity to extend two together geographically and in terms of device contributions. By joining or acquiring added parties, drug operations can obtain better effectiveness, access new markets, and expand their fruit notebooks.
This trend towards combination shows no signs of lessening. As guests continue to inquire about tumor opportunities and functional effectiveness, a further combination within two together the stigmatized and general sectors is expected.
Inevitably, as the generics manufacturing consolidates, individual or more of the larger generics associations concede the possibility enhance acquisition marks for Big Pharma guests. Such earnings could determine Big Pharma's accompanying approach to a broader range of common brands and markets, in addition to opportunities to influence savings of scale and streamline movements.
Overall, the flow towards fortification is a defining characteristic of drug manufacturing, compelled by economic necessity and the occupation of calculated growth excuse.
Research Method
Introduction:
The research methods working in this place study serve as the support for assemblage and resolving data to address the research questions efficiently. It outlines the orderly approach used to guarantee the genuineness and dependability of the study's verdicts.
Research Design
For this research, an assorted-arrangements approach was selected to connect concerning qualities not quantities, and quantitative dossier accumulation forms. This approach allows for an inclusive understanding of the research matter by merging two together mathematical dossier and in-depth subjective understandings.
Data Collection Methods
Data accumulation orders contained surveys executed to a sample community and a wheeled vehicle for hauling organized interviews accompanying key collaborators. Surveys provided an all-inclusive dossier on mathematical news and stances, while interviews presented concerning qualities, not quantities acumens into parties' occurrences and outlooks.
Sample Population and Sampling Techniques:
The sample population contained [depict the traits of the sample state, in the way that headcount or distinguishing tests]. Sampling methods, to a degree random examination or purposive savoring, were working to guarantee the representativeness and pertinence of the sample to the research goals.
Data Analysis Methods
Data study complicated two together all-inclusive and concerning qualities not quantities methods. Quantitative data from surveys were resolved to utilize mathematical forms to label patterns and equations. Qualitative data from interviews were resolved thematically to reveal key ideas and insights.
Ethical Considerations
Ethical concerns were superior during the whole of the research process. Informed consent was acquired from all shareholders, and their solitude and secrecy were rigidly asserted. The research hewed to moral guidelines and principles to guarantee the prosperity and rights of partners.
Results
Presentation of Findings
The results of the study are bestowed in a clear and systematized style, appropriating tables, charts, and graphs to decorate key verdicts. Quantitative data are summarized utilizing explanatory enumerations, while subjective observations are bestowed through excerpts from interviews.
Data Analysis
Quantitative dossier reasoning disclosed [recap key determinable findings] while concerning qualities, not quantities study recognized [climax key concerning qualities, not quantities ideas or judgments]. The unification of two together all-inclusive and qualitative data supported an inclusive understanding of the research business.
Summary of Results
Overall, the results display [concisely compile the main judgments of the study]. These judgments form the base for further dispute and interpretation in the following divisions.
Interpretation of Results
The understanding of results includes resolving the judgments in the framework of existent information and hypothetical foundations. It inquires to uncover the fundamental aims and associations of the results for the research problem.
Implications of Findings
The associations of the verdicts are surveyed concerning their meaning for belief, practice, and procedure. This includes reviewing what the results enhance existent information, updating in charge, and addressing experienced challenges or moments.
Limitations
Despite the strictness of the research methods, several restraints concede the possibility to be recognized. These grant permissions contain [label and confer potential restraints to a degree sample breadth, bias, or scope]. Recognizing these disadvantages helps investigate the judgments and desires paths for future research.
Future Research Directions
Based on the verdicts concerning this study, various paths for future research may be labeled. These may contain [plan potential fields for future research established break or unchallenged questions exposed apiece study]. Addressing these fields can further advance understanding of engagement.
Conclusion
Summary of Key Points
In summary, this study has supported valuable insights into [sum up the main verdicts and gifts of the study]. The unification of all-inclusive and approximate dossier has improved our understanding of the research issue.
Significance of the Study
The importance concerning this study lies in allure offering to [examine the more extensive meaning of the research, in the way that hypothetical progresses, useful associations, or policy pieces of advice]. It fills a breach in the research and offers valuable intuitions for investigators, experts, and policymakers.
Recommendations
Based on the verdicts, various approvals may be fashioned for [suggest experienced approvals or conduct established the study's associations]. These approvals aim to [define the intended impact or effect of the approvals].
Final Remarks
In conclusion, this study has cleared up [reiterate the significance and pertinence of the study]. It has supported valuable intuitions that can update future research, practice, and tactics engaged. Overall, the verdicts influence a deeper understanding of [epitomize the fuller implications of the study].
Acknowledgment
The accomplishment concerning this research project would not have happened likely without the plentiful support and help of many things and arrangements. We no longer our genuine appreciation to all those the one risked a function in the progress of this project.
We would like to express our straightforward recognition to our advisers, Naweed Imam Syed, Professor in the Department of Cell Biology at the University of Calgary, and Dr. Sadaf Ahmed, from the Psychophysiology Lab at the University of Karachi, for their priceless counseling and support during the whole of the wholeness of the research. Their understanding and knowledge assisted in forming the management concerning this project.
Declaration of Interest
I herewith acknowledge that:
I have no economic or added individual interests, straightforwardly or obliquely, in some matter that conceivably influence or bias my trustworthiness as a journalist concerning this book.
Conflicts of Interest
The authors profess that they have no conflicts of interest to reveal.
Financial Support and Protection
No external funding for a project was taken to assist with the prepareation of this manuscript
Clearly Auctoresonline and particularly Psychology and Mental Health Care Journal is dedicated to improving health care services for individuals and populations. The editorial boards' ability to efficiently recognize and share the global importance of health literacy with a variety of stakeholders. Auctoresonline publishing platform can be used to facilitate of optimal client-based services and should be added to health care professionals' repertoire of evidence-based health care resources.
Journal of Clinical Cardiology and Cardiovascular Intervention The submission and review process was adequate. However I think that the publication total value should have been enlightened in early fases. Thank you for all.
Journal of Women Health Care and Issues By the present mail, I want to say thank to you and tour colleagues for facilitating my published article. Specially thank you for the peer review process, support from the editorial office. I appreciate positively the quality of your journal.
Journal of Clinical Research and Reports I would be very delighted to submit my testimonial regarding the reviewer board and the editorial office. The reviewer board were accurate and helpful regarding any modifications for my manuscript. And the editorial office were very helpful and supportive in contacting and monitoring with any update and offering help. It was my pleasure to contribute with your promising Journal and I am looking forward for more collaboration.
We would like to thank the Journal of Thoracic Disease and Cardiothoracic Surgery because of the services they provided us for our articles. The peer-review process was done in a very excellent time manner, and the opinions of the reviewers helped us to improve our manuscript further. The editorial office had an outstanding correspondence with us and guided us in many ways. During a hard time of the pandemic that is affecting every one of us tremendously, the editorial office helped us make everything easier for publishing scientific work. Hope for a more scientific relationship with your Journal.
The peer-review process which consisted high quality queries on the paper. I did answer six reviewers’ questions and comments before the paper was accepted. The support from the editorial office is excellent.
Journal of Neuroscience and Neurological Surgery. I had the experience of publishing a research article recently. The whole process was simple from submission to publication. The reviewers made specific and valuable recommendations and corrections that improved the quality of my publication. I strongly recommend this Journal.
Dr. Katarzyna Byczkowska My testimonial covering: "The peer review process is quick and effective. The support from the editorial office is very professional and friendly. Quality of the Clinical Cardiology and Cardiovascular Interventions is scientific and publishes ground-breaking research on cardiology that is useful for other professionals in the field.
Thank you most sincerely, with regard to the support you have given in relation to the reviewing process and the processing of my article entitled "Large Cell Neuroendocrine Carcinoma of The Prostate Gland: A Review and Update" for publication in your esteemed Journal, Journal of Cancer Research and Cellular Therapeutics". The editorial team has been very supportive.
Testimony of Journal of Clinical Otorhinolaryngology: work with your Reviews has been a educational and constructive experience. The editorial office were very helpful and supportive. It was a pleasure to contribute to your Journal.
Dr. Bernard Terkimbi Utoo, I am happy to publish my scientific work in Journal of Women Health Care and Issues (JWHCI). The manuscript submission was seamless and peer review process was top notch. I was amazed that 4 reviewers worked on the manuscript which made it a highly technical, standard and excellent quality paper. I appreciate the format and consideration for the APC as well as the speed of publication. It is my pleasure to continue with this scientific relationship with the esteem JWHCI.
This is an acknowledgment for peer reviewers, editorial board of Journal of Clinical Research and Reports. They show a lot of consideration for us as publishers for our research article “Evaluation of the different factors associated with side effects of COVID-19 vaccination on medical students, Mutah university, Al-Karak, Jordan”, in a very professional and easy way. This journal is one of outstanding medical journal.
Dear Hao Jiang, to Journal of Nutrition and Food Processing We greatly appreciate the efficient, professional and rapid processing of our paper by your team. If there is anything else we should do, please do not hesitate to let us know. On behalf of my co-authors, we would like to express our great appreciation to editor and reviewers.
As an author who has recently published in the journal "Brain and Neurological Disorders". I am delighted to provide a testimonial on the peer review process, editorial office support, and the overall quality of the journal. The peer review process at Brain and Neurological Disorders is rigorous and meticulous, ensuring that only high-quality, evidence-based research is published. The reviewers are experts in their fields, and their comments and suggestions were constructive and helped improve the quality of my manuscript. The review process was timely and efficient, with clear communication from the editorial office at each stage. The support from the editorial office was exceptional throughout the entire process. The editorial staff was responsive, professional, and always willing to help. They provided valuable guidance on formatting, structure, and ethical considerations, making the submission process seamless. Moreover, they kept me informed about the status of my manuscript and provided timely updates, which made the process less stressful. The journal Brain and Neurological Disorders is of the highest quality, with a strong focus on publishing cutting-edge research in the field of neurology. The articles published in this journal are well-researched, rigorously peer-reviewed, and written by experts in the field. The journal maintains high standards, ensuring that readers are provided with the most up-to-date and reliable information on brain and neurological disorders. In conclusion, I had a wonderful experience publishing in Brain and Neurological Disorders. The peer review process was thorough, the editorial office provided exceptional support, and the journal's quality is second to none. I would highly recommend this journal to any researcher working in the field of neurology and brain disorders.
Dear Agrippa Hilda, Journal of Neuroscience and Neurological Surgery, Editorial Coordinator, I trust this message finds you well. I want to extend my appreciation for considering my article for publication in your esteemed journal. I am pleased to provide a testimonial regarding the peer review process and the support received from your editorial office. The peer review process for my paper was carried out in a highly professional and thorough manner. The feedback and comments provided by the authors were constructive and very useful in improving the quality of the manuscript. This rigorous assessment process undoubtedly contributes to the high standards maintained by your journal.
International Journal of Clinical Case Reports and Reviews. I strongly recommend to consider submitting your work to this high-quality journal. The support and availability of the Editorial staff is outstanding and the review process was both efficient and rigorous.
Thank you very much for publishing my Research Article titled “Comparing Treatment Outcome Of Allergic Rhinitis Patients After Using Fluticasone Nasal Spray And Nasal Douching" in the Journal of Clinical Otorhinolaryngology. As Medical Professionals we are immensely benefited from study of various informative Articles and Papers published in this high quality Journal. I look forward to enriching my knowledge by regular study of the Journal and contribute my future work in the field of ENT through the Journal for use by the medical fraternity. The support from the Editorial office was excellent and very prompt. I also welcome the comments received from the readers of my Research Article.
Dear Erica Kelsey, Editorial Coordinator of Cancer Research and Cellular Therapeutics Our team is very satisfied with the processing of our paper by your journal. That was fast, efficient, rigorous, but without unnecessary complications. We appreciated the very short time between the submission of the paper and its publication on line on your site.
I am very glad to say that the peer review process is very successful and fast and support from the Editorial Office. Therefore, I would like to continue our scientific relationship for a long time. And I especially thank you for your kindly attention towards my article. Have a good day!
"We recently published an article entitled “Influence of beta-Cyclodextrins upon the Degradation of Carbofuran Derivatives under Alkaline Conditions" in the Journal of “Pesticides and Biofertilizers” to show that the cyclodextrins protect the carbamates increasing their half-life time in the presence of basic conditions This will be very helpful to understand carbofuran behaviour in the analytical, agro-environmental and food areas. We greatly appreciated the interaction with the editor and the editorial team; we were particularly well accompanied during the course of the revision process, since all various steps towards publication were short and without delay".
I would like to express my gratitude towards you process of article review and submission. I found this to be very fair and expedient. Your follow up has been excellent. I have many publications in national and international journal and your process has been one of the best so far. Keep up the great work.
We are grateful for this opportunity to provide a glowing recommendation to the Journal of Psychiatry and Psychotherapy. We found that the editorial team were very supportive, helpful, kept us abreast of timelines and over all very professional in nature. The peer review process was rigorous, efficient and constructive that really enhanced our article submission. The experience with this journal remains one of our best ever and we look forward to providing future submissions in the near future.
I am very pleased to serve as EBM of the journal, I hope many years of my experience in stem cells can help the journal from one way or another. As we know, stem cells hold great potential for regenerative medicine, which are mostly used to promote the repair response of diseased, dysfunctional or injured tissue using stem cells or their derivatives. I think Stem Cell Research and Therapeutics International is a great platform to publish and share the understanding towards the biology and translational or clinical application of stem cells.
I would like to give my testimony in the support I have got by the peer review process and to support the editorial office where they were of asset to support young author like me to be encouraged to publish their work in your respected journal and globalize and share knowledge across the globe. I really give my great gratitude to your journal and the peer review including the editorial office.
I am delighted to publish our manuscript entitled "A Perspective on Cocaine Induced Stroke - Its Mechanisms and Management" in the Journal of Neuroscience and Neurological Surgery. The peer review process, support from the editorial office, and quality of the journal are excellent. The manuscripts published are of high quality and of excellent scientific value. I recommend this journal very much to colleagues.
Dr.Tania Muñoz, My experience as researcher and author of a review article in The Journal Clinical Cardiology and Interventions has been very enriching and stimulating. The editorial team is excellent, performs its work with absolute responsibility and delivery. They are proactive, dynamic and receptive to all proposals. Supporting at all times the vast universe of authors who choose them as an option for publication. The team of review specialists, members of the editorial board, are brilliant professionals, with remarkable performance in medical research and scientific methodology. Together they form a frontline team that consolidates the JCCI as a magnificent option for the publication and review of high-level medical articles and broad collective interest. I am honored to be able to share my review article and open to receive all your comments.
“The peer review process of JPMHC is quick and effective. Authors are benefited by good and professional reviewers with huge experience in the field of psychology and mental health. The support from the editorial office is very professional. People to contact to are friendly and happy to help and assist any query authors might have. Quality of the Journal is scientific and publishes ground-breaking research on mental health that is useful for other professionals in the field”.
Dear editorial department: On behalf of our team, I hereby certify the reliability and superiority of the International Journal of Clinical Case Reports and Reviews in the peer review process, editorial support, and journal quality. Firstly, the peer review process of the International Journal of Clinical Case Reports and Reviews is rigorous, fair, transparent, fast, and of high quality. The editorial department invites experts from relevant fields as anonymous reviewers to review all submitted manuscripts. These experts have rich academic backgrounds and experience, and can accurately evaluate the academic quality, originality, and suitability of manuscripts. The editorial department is committed to ensuring the rigor of the peer review process, while also making every effort to ensure a fast review cycle to meet the needs of authors and the academic community. Secondly, the editorial team of the International Journal of Clinical Case Reports and Reviews is composed of a group of senior scholars and professionals with rich experience and professional knowledge in related fields. The editorial department is committed to assisting authors in improving their manuscripts, ensuring their academic accuracy, clarity, and completeness. Editors actively collaborate with authors, providing useful suggestions and feedback to promote the improvement and development of the manuscript. We believe that the support of the editorial department is one of the key factors in ensuring the quality of the journal. Finally, the International Journal of Clinical Case Reports and Reviews is renowned for its high- quality articles and strict academic standards. The editorial department is committed to publishing innovative and academically valuable research results to promote the development and progress of related fields. The International Journal of Clinical Case Reports and Reviews is reasonably priced and ensures excellent service and quality ratio, allowing authors to obtain high-level academic publishing opportunities in an affordable manner. I hereby solemnly declare that the International Journal of Clinical Case Reports and Reviews has a high level of credibility and superiority in terms of peer review process, editorial support, reasonable fees, and journal quality. Sincerely, Rui Tao.
Clinical Cardiology and Cardiovascular Interventions I testity the covering of the peer review process, support from the editorial office, and quality of the journal.
Clinical Cardiology and Cardiovascular Interventions, we deeply appreciate the interest shown in our work and its publication. It has been a true pleasure to collaborate with you. The peer review process, as well as the support provided by the editorial office, have been exceptional, and the quality of the journal is very high, which was a determining factor in our decision to publish with you.
The peer reviewers process is quick and effective, the supports from editorial office is excellent, the quality of journal is high. I would like to collabroate with Internatioanl journal of Clinical Case Reports and Reviews journal clinically in the future time.
Clinical Cardiology and Cardiovascular Interventions, I would like to express my sincerest gratitude for the trust placed in our team for the publication in your journal. It has been a true pleasure to collaborate with you on this project. I am pleased to inform you that both the peer review process and the attention from the editorial coordination have been excellent. Your team has worked with dedication and professionalism to ensure that your publication meets the highest standards of quality. We are confident that this collaboration will result in mutual success, and we are eager to see the fruits of this shared effort.
Dear Dr. Jessica Magne, Editorial Coordinator 0f Clinical Cardiology and Cardiovascular Interventions, I hope this message finds you well. I want to express my utmost gratitude for your excellent work and for the dedication and speed in the publication process of my article titled "Navigating Innovation: Qualitative Insights on Using Technology for Health Education in Acute Coronary Syndrome Patients." I am very satisfied with the peer review process, the support from the editorial office, and the quality of the journal. I hope we can maintain our scientific relationship in the long term.
Dear Monica Gissare, - Editorial Coordinator of Nutrition and Food Processing. ¨My testimony with you is truly professional, with a positive response regarding the follow-up of the article and its review, you took into account my qualities and the importance of the topic¨.
Dear Dr. Jessica Magne, Editorial Coordinator 0f Clinical Cardiology and Cardiovascular Interventions, The review process for the article “The Handling of Anti-aggregants and Anticoagulants in the Oncologic Heart Patient Submitted to Surgery” was extremely rigorous and detailed. From the initial submission to the final acceptance, the editorial team at the “Journal of Clinical Cardiology and Cardiovascular Interventions” demonstrated a high level of professionalism and dedication. The reviewers provided constructive and detailed feedback, which was essential for improving the quality of our work. Communication was always clear and efficient, ensuring that all our questions were promptly addressed. The quality of the “Journal of Clinical Cardiology and Cardiovascular Interventions” is undeniable. It is a peer-reviewed, open-access publication dedicated exclusively to disseminating high-quality research in the field of clinical cardiology and cardiovascular interventions. The journal's impact factor is currently under evaluation, and it is indexed in reputable databases, which further reinforces its credibility and relevance in the scientific field. I highly recommend this journal to researchers looking for a reputable platform to publish their studies.
Dear Editorial Coordinator of the Journal of Nutrition and Food Processing! "I would like to thank the Journal of Nutrition and Food Processing for including and publishing my article. The peer review process was very quick, movement and precise. The Editorial Board has done an extremely conscientious job with much help, valuable comments and advices. I find the journal very valuable from a professional point of view, thank you very much for allowing me to be part of it and I would like to participate in the future!”
Dealing with The Journal of Neurology and Neurological Surgery was very smooth and comprehensive. The office staff took time to address my needs and the response from editors and the office was prompt and fair. I certainly hope to publish with this journal again.Their professionalism is apparent and more than satisfactory. Susan Weiner
My Testimonial Covering as fellowing: Lin-Show Chin. The peer reviewers process is quick and effective, the supports from editorial office is excellent, the quality of journal is high. I would like to collabroate with Internatioanl journal of Clinical Case Reports and Reviews.
My experience publishing in Psychology and Mental Health Care was exceptional. The peer review process was rigorous and constructive, with reviewers providing valuable insights that helped enhance the quality of our work. The editorial team was highly supportive and responsive, making the submission process smooth and efficient. The journal's commitment to high standards and academic rigor makes it a respected platform for quality research. I am grateful for the opportunity to publish in such a reputable journal.
My experience publishing in International Journal of Clinical Case Reports and Reviews was exceptional. I Come forth to Provide a Testimonial Covering the Peer Review Process and the editorial office for the Professional and Impartial Evaluation of the Manuscript.
